⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
ACAD News
Acadia Pharmaceuticals Inc.
Acadia Pharmaceuticals to Participate in the Canaccord Genuity 46th Annual Growth Conference
businesswire.com
ACAD
American College of Surgeons and Arcadia Collaborate to Improve Surgical Patient Outcomes
prnewswire.com
ACAD
Parkinson's Disease Clinical Trial Pipeline Boom as 150+ Companies are in the Race for Better Treatments | DelveInsight
globenewswire.com
ANVS
SUPN
ABBV
VNDA
JAZZ
ACAD
MRK
Acadia Pharmaceuticals to Announce Second Quarter 2026 Financial Results on August 4, 2026
businesswire.com
ACAD
Acadia Pharmaceuticals Appoints Carl Segerstrom as Chief People Officer
businesswire.com
ACAD
DAYBU® (trofinetyd) zalecany w UE przez CHMP do stosowania w leczeniu zespołu Retta
businesswire.com
ACAD
DAYBU® (trofinetida) recibe una recomendación positiva por parte del CHMP para su aprobación en la Unión Europea
businesswire.com
ACAD
Malattie rare – Dal CHMP parere positivo per trofinetide per il trattamento della sindrome di Rett
businesswire.com
ACAD
DAYBU® (Trofinetide) vom CHMP für die Zulassung in der Europäischen Union empfohlen
businesswire.com
ACAD
DAYBU® (trofinétide) recommandé dans l’UE par le CHMP pour le traitement du syndrome de Rett
businesswire.com
ACAD